Th Witthoeft

Summary

Country: Germany

Publications

  1. ncbi Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany
    Thomas Witthöft
    Medical Clinic I, Division of Gastroenterology, University of Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Int J Colorectal Dis 20:18-23. 2005
  2. ncbi Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study
    Th Witthoeft
    University Hospital Schleswig Holstein Campus Luebeck, Department of Medicine I, Division of Gastroenterology, Luebeck 23538, Germany
    World J Gastroenterol 13:579-84. 2007
  3. ncbi Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial
    Th Witthöft
    Medical Department I, Division of Gastroenterology, University Hospital Schleswig Holstein Campus Lübeck, Lubeck, Germany
    J Viral Hepat 14:788-96. 2007

Collaborators

Detail Information

Publications3

  1. ncbi Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany
    Thomas Witthöft
    Medical Clinic I, Division of Gastroenterology, University of Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Int J Colorectal Dis 20:18-23. 2005
    ..The aim was to evaluate the efficacy and safety of repeated treatment with infliximab in patients with chronic active Crohn's disease under routine conditions in clinics and private practices...
  2. ncbi Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study
    Th Witthoeft
    University Hospital Schleswig Holstein Campus Luebeck, Department of Medicine I, Division of Gastroenterology, Luebeck 23538, Germany
    World J Gastroenterol 13:579-84. 2007
    ..To investigate the use of high dose consensus-interferon in combination with ribavirin in former iv drug users infected with hepatitis C...
  3. ncbi Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial
    Th Witthöft
    Medical Department I, Division of Gastroenterology, University Hospital Schleswig Holstein Campus Lübeck, Lubeck, Germany
    J Viral Hepat 14:788-96. 2007
    ..This investigation confirms the well-known risk-benefit ratio found in controlled studies in a clinical practice setting. The safety profile is similar and shows the highest incidence of adverse events in the first 12 weeks of treatment...